MEDINET Co., Ltd. (TYO:2370)

Japan flag Japan · Delayed Price · Currency is JPY
29.00
0.00 (0.00%)
Apr 17, 2026, 3:30 PM JST
Market Cap7.99B -18.4%
Revenue (ttm)998.00M -41.4%
Net Income-3.05B
EPS-26.77
Shares Out275.52M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,866,700
Average Volume721,865
Open30.00
Previous Close29.00
Day's Range29.00 - 30.00
52-Week Range27.00 - 43.00
Beta0.27
RSI44.77
Earnings DateMay 8, 2026

About MEDINET

MEDINET Co., Ltd. operates as a contract development and manufacturing organization that provides regenerative medicine and cell therapy solutions in Japan. It operates through two segments: Cell Processing Business and Regenerative Medicine Products Business.The company’s solutions include technical know-how, facilities, systems, materials, professional cell-engineers, and other requirements to conduct immuno-cell therapy.It also manufactures regenerative medical/investigational and specified cell products. In addition, the company offers valu... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1995
Employees 92
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 2370
Full Company Profile

Financial Performance

In fiscal year 2018, MEDINET's revenue was 998.00 million, a decrease of -41.43% compared to the previous year's 1.70 billion. Losses were -3.05 billion, 17.1% more than in 2017.

Financial Statements